MyDacla (generic Daklinza Daclatasvir) is now available in India mfg by Mylan Pharma.

MyDacla (generic Daklinza Daclatasvir) must not be administered as monotherapy. MyDacla (generic Daklinza Daclatasvir) must be administered in combination with other medicinal products for the treatment of chronic HCV infection.

MyDacla (generic Daklinza Daclatasvir) is indicated for use with sofosbuvir for the treatment of patients with chronic HCV genotype 3 infection. Sustained virologic response (SVR) rates are reduced in HCV genotype 3-infected patients with cirrhosis receiving this regimen. Treatment with MyDacla (generic Daklinza Daclatasvir) should be initiated and monitored by a physician experienced in the management of chronic hepatitis C.

Kindly note

We are not an online pharmacy and all our shipments are exported after approval from the Assistant Drugs Controller and clearance through Indian customs.

We do not supply Narcotics & Controlled substances.

Avalon Pharma Pvt. Ltd only provides information and we do not recommend any drug or give medical advice. Whether a medication is right for you is a decision between the patient and the prescribing doctor. The content of this site should not be a substitute for professional medical advice, diagnosis or any treatment.

All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.